| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 761 | 2019 |
| Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference MM Mueller, H Van Remoortel, P Meybohm, K Aranko, C Aubron, ... Jama 321 (10), 983-997, 2019 | 574 | 2019 |
| Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies M Scully, S Cataland, P Coppo, J De La Rubia, KD Friedman, JK Hovinga, ... Journal of thrombosis and haemostasis 15 (2), 312-322, 2017 | 422 | 2017 |
| HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management K Pavenski, J Freedman, JW Semple Tissue antigens 79 (4), 237-245, 2012 | 206 | 2012 |
| Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD Z Harel, M Sholzberg, PS Shah, K Pavenski, S Harel, R Wald, CM Bell, ... Journal of the American Society of Nephrology 25 (3), 431-442, 2014 | 145 | 2014 |
| Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial J Callum, ME Farkouh, DC Scales, NM Heddle, M Crowther, V Rao, ... Jama 322 (20), 1966-1976, 2019 | 136 | 2019 |
| International Working Group for Thrombotic Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related … M Scully, S Cataland, P Coppo, J de la Rubia, KD Friedman, ... J Thromb Haemost 15 (2), 312-322, 2017 | 136 | 2017 |
| Redefining outcomes in immune TTP: an international working group consensus report A Cuker, SR Cataland, P Coppo, J de La Rubia, KD Friedman, JN George, ... Blood, The Journal of the American Society of Hematology 137 (14), 1855-1861, 2021 | 129 | 2021 |
| Proceedings of a consensus conference: pathogen inactivation—making decisions about new technologies KE Webert, CM Cserti, J Hannon, Y Lin, K Pavenski, JM Pendergrast, ... Transfusion Medicine Reviews 22 (1), 1-34, 2008 | 118 | 2008 |
| Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia S Nahirniak, SJ Slichter, S Tanael, P Rebulla, K Pavenski, R Vassallo, ... Transfusion medicine reviews 29 (1), 3-13, 2015 | 106 | 2015 |
| Compliance with a massive transfusion protocol (MTP) impacts patient outcome M Bawazeer, N Ahmed, H Izadi, A McFarlan, A Nathens, K Pavenski Injury 46 (1), 21-28, 2015 | 90 | 2015 |
| Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis T Kei, N Mistry, G Curley, K Pavenski, N Shehata, RM Tanzini, ... Canadian Journal of Anesthesia, 1-16, 2019 | 74 | 2019 |
| Red blood cell storage lesions and related transfusion issues: a Canadian Blood Services research and development symposium K Pavenski, E Saidenberg, M Lavoie, M Tokessy, DR Branch Transfusion medicine reviews 26 (1), 68-84, 2012 | 66 | 2012 |
| HERCULES Investigators Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... N Engl J Med 380 (4), 335-346, 2019 | 60 | 2019 |
| Efficacy of HLA‐matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review K Pavenski, P Rebulla, R Duquesnoy, CL Saw, SJ Slichter, S Tanael, ... Transfusion 53 (10), 2230-2242, 2013 | 60 | 2013 |
| Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study P Knoebl, S Cataland, F Peyvandi, P Coppo, M Scully, ... Journal of thrombosis and haemostasis 18 (2), 479-484, 2020 | 57 | 2020 |
| Posttransfusion platelet count increments after ABO‐compatible versus ABO‐incompatible platelet transfusions in noncancer patients: an observational study K Pavenski, TE Warkentin, H Shen, Y Liu, NM Heddle Transfusion 50 (7), 1552-1560, 2010 | 51 | 2010 |
| Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis F Peyvandi, S Cataland, M Scully, P Coppo, P Knoebl, ... Blood advances 5 (8), 2137-2141, 2021 | 49 | 2021 |
| Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review M Kjær, G Bertrand, T Bakchoul, E Massey, JM Baker, L Lieberman, ... Vox sanguinis 114 (1), 79-94, 2019 | 45 | 2019 |
| Human leukocyte antigen alloimmunization and alloimmune platelet refractoriness A Saris, K Pavenski Transfusion Medicine Reviews 34 (4), 250-257, 2020 | 42 | 2020 |
